Filing Details

Accession Number:
0000711377-19-000053
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-05 18:11:49
Reporting Period:
2019-11-01
Accepted Time:
2019-11-05 18:11:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-11-01 20,000 $64.81 247,311 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 186,970 Direct
Footnotes
  1. The shares were sold under the terms of a Rule 10b5-1 plan filed by the Reporting Person on October 1, 2019
  2. The shares were sold from an limited liability company in which Mr. Herbert and his spouse hold minority financial positions; 200,209 shares remain in the LLCs. 39,568 shares are held jointly by Mr. Herbert and his spouse. 7434 shares are held in trust for Mr. Herbert's spouse and 100 shares are in a charitable remainder trust in which Mr. Herbert and his spouse are trustees and beneficiaries.